Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered CD46-specific effector cells and uses thereof in the treatment of cancer

Engineered CD46-specific effector cells and uses thereof in the treatment of cancer

US Patent 12049511 · Granted Jul 30, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TREM2 antibodies and methods of use thereof2025
Immunoconjugates targeting CD46 and methods of use thereof2024
Immunoconjugates targeting CD46 and methods of use thereof2022
Monoclonal antibodies and methods of use2022
Anti-TREM2 antibodies and methods of use thereof2021
Ionic liquid-tolerant cellulase enzymes2019
Ionic liquid-tolerant cellulase enzymes2017
Monoclonal canine CD20 antibodies and methods of use2017
Thermophilic cellobiohydrolase2017
Microarrays and uses therefor2014
Methods and compositions for inducing apoptosis in cancer cells with an anti-DR52012
Methods and compositions for treating allergic diseases2012